Based on this, the hypothesis that YXF alleviates myocardial fibrosis in DCM by upregulating miR‐133a and inhibiting the TGF‐β/Smads signaling pathway deserves further investigation. The gene discussed is TGFB1; the disease is Myocardial fibrosis.